ArticleBlood advances2022

SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab.

Mario L Marques-Piubelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.